Beyond Air, Inc. Employee Benefits and Share-based Compensation
Beyond Air, Inc. (XAIR) reported Employee Benefits and Share-based Compensation of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-08-13
- Beyond Air, Inc. employee benefits and share-based compensation for the quarter ending 2026-06-30 was $100.00K, a 50.00% decline year-over-year.
- Beyond Air, Inc. employee benefits and share-based compensation for the quarter ending 2025-09-30 was $200.00K, a 33.33% decline year-over-year.
- Beyond Air, Inc. employee benefits and share-based compensation for the quarter ending 2025-06-30 was $200.00K, a 33.33% decline year-over-year.
- Beyond Air, Inc. employee benefits and share-based compensation for the quarter ending 2025-03-31 was $100.00K.
- Beyond Air, Inc. employee benefits and share-based compensation for fiscal 2026 was $500.00K, a 50.00% decline from fiscal 2025.
- Beyond Air, Inc. employee benefits and share-based compensation for fiscal 2025 was $1.00M, a 54.55% decline from fiscal 2024.
- Beyond Air, Inc. employee benefits and share-based compensation for fiscal 2024 was $2.20M, a 8.33% decline from fiscal 2023.
- Beyond Air, Inc. employee benefits and share-based compensation for fiscal 2023 was $2.40M, a 41.18% increase from fiscal 2022.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 3 month as first filed | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 6 month as first filed | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 9 month as first filed | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | $500.00K 10-K · filed 2026-06-26 | ||||||
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-10 | $300.00K 10-Q · filed 2025-11-10 | $500.00K derived: sum of 3 quarters · filed 2026-08-13 | $800.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $200.00K 10-Q · filed 2026-08-13 | $300.00K derived: sum of 2 quarters · filed 2026-08-13 | $600.00K derived: sum of 3 quarters · filed 2026-08-13 | $900.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $400.00K derived: sum of 2 quarters · filed 2026-06-26 | $700.00K derived: sum of 3 quarters · filed 2026-06-26 | $1.00M 10-K · filed 2026-06-26 | |||
| 2024-12-31 | $300.00K 10-Q · filed 2025-02-10 | $600.00K derived: sum of 2 quarters · filed 2025-11-10 | $900.00K 10-Q · filed 2025-02-10 | $900.00K derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-10 | $600.00K 10-Q · filed 2025-11-10 | $600.00K derived: sum of 3 quarters · filed 2025-11-10 | $1.30M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-12 | $300.00K derived: sum of 2 quarters · filed 2025-08-12 | $1.00M derived: sum of 3 quarters · filed 2025-08-12 | $1.70M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $700.00K derived: sum of 2 quarters · filed 2025-06-20 | $1.40M derived: sum of 3 quarters · filed 2025-06-20 | $2.20M 10-K · filed 2025-06-20 | |||
| 2023-12-31 | $700.00K 10-Q · filed 2025-02-10 | $1.40M derived: sum of 2 quarters · filed 2025-02-10 | $2.20M 10-Q · filed 2025-02-10 | $2.50M derived: sum of 4 quarters · filed 2025-02-10 | |||
| 2023-09-30 | $700.00K 10-Q · filed 2024-11-12 | $1.50M 10-Q · filed 2024-11-12 | $1.80M derived: sum of 3 quarters · filed 2024-11-12 | $2.40M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $700.00K 10-Q · filed 2024-08-06 | $714.00K 10-Q · filed 2023-08-10 | $1.10M derived: sum of 2 quarters · filed 2024-08-06 | $1.70M derived: sum of 3 quarters · filed 2024-08-06 | $2.40M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | $1.00M derived: sum of 2 quarters · filed 2024-06-24 | $1.70M derived: sum of 3 quarters · filed 2024-06-24 | $2.40M 10-K · filed 2024-06-24 | |||
| 2022-12-31 | $600.00K 10-Q · filed 2024-02-12 | $588.00K 10-Q · filed 2023-02-10 | $1.30M derived: sum of 2 quarters · filed 2024-02-12 | $2.00M 10-Q · filed 2024-02-12 | $1.98M 10-Q · filed 2023-02-10 | $2.44M derived: sum of 4 quarters · filed 2024-02-12 | |
| 2022-09-30 | $700.00K 10-Q · filed 2023-11-13 | $701.00K 10-Q · filed 2022-11-08 | $1.40M 10-Q · filed 2023-11-13 | $1.40M 10-Q · filed 2022-11-08 | $1.84M derived: sum of 3 quarters · filed 2023-11-13 | $2.77M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $694.00K 10-Q · filed 2023-08-10 | $1.15M derived: sum of 2 quarters · filed 2023-08-10 | $2.08M derived: sum of 3 quarters · filed 2023-08-10 | $2.24M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $451.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | $1.38M derived: sum of 2 quarters · filed 2023-06-22 | $1.54M derived: sum of 3 quarters · filed 2023-06-22 | $1.70M 10-K · filed 2023-06-22 | |||
| 2021-12-31 | $930.00K 10-Q · filed 2023-02-10 | $1.09M derived: sum of 2 quarters · filed 2023-02-10 | $1.25M 10-Q · filed 2023-02-10 | ||||
| 2021-09-30 | $161.00K 10-Q · filed 2022-11-08 | $319.00K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |